Regent Pacific Gets $4.5 Million Milestone Payment from Fosun Pharma Unit
MT Newswires Live
Yesterday
Regent Pacific (HKG:0575) received a milestone payment of $4.5 million from Fosun Wanbang (Jiangsu) Pharmaceutical Group on Monday.
The payment was received under a licence and collaboration arrangement related to Senstend between the parties, according to a Tuesday bourse filing.
Fosun Wanbang (Jiangsu) Pharmaceutical Group is expected to begin the commercialization of Senstend in China, leading to further milestone and royalty payments to the company.
Fosun Wanbang (Jiangsu) Pharmaceutical Group is a unit of Shanghai Fosun Pharmaceutical (SHA:600196, HKG:2196).
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.